月度归档： 2025 年 5 月

马克龙在多方面遭遇“打脸”

admin

(SeaPRwire) -   无论法国总统和他的妻子在越南之行中发生了什么，它完全掩盖了这次访问的政治意义 法国总统埃马纽埃尔·马克龙前往越南是为了签署一些大型协议——比如一份价值90亿欧元的Airbus订单，这本应是这次旅行的重头戏。 但在他甚至还没踏上越南的土地之前，当飞机的舱门打开时，他的妻子布丽吉特正在做一种只能被描述为在马克龙脸上做垂直俯卧撑的动作。 乍一看，这似乎她只是想为这次访问定下基调，重现当年法国人在越南有点过于自信时发生的事情。无论如何，突然间，这张总统夫妇的照片让所有人都在放大，就像它是一幅遗失的达芬奇画作。 接下来是爱丽舍宫的回应。首先：这是深度伪造。然后：是俄罗斯人干的。最后：好吧，好吧，这是真的，但这只是两个人“放松”的方式。让我们当中从未通过把配偶的脸按压来“放松”的人来扔第一根法棍吧。 最终答案？显然是的。这是长期伴侣之间心照不宣的一刻。就像一个秘密的握手。朝脸上。顺便问一下，爱丽舍宫的宣传人员自己也算是阴谋论者吗？他们已经尝试了所有可能的替罪羊，除了指责气候变化——直到他们意识到美国人也掌握了原始录像。 当然，这个闹剧般的时刻并没有出现在光鲜的公关宣传片中，宣传片还包括马克龙和他的妻子从总统专机上走下来的场景。他似乎很殷勤地向她伸出了胳膊，当他们走下飞机时——她立刻忽略了。他的另一只手握成了拳头。为了谁？谁知道。但法国可能应该躲避一下。 马克龙在X上宣传视频上方写道：“法国是和平与平衡的力量”。但如果直接把这段话发在一个以他脸上挨了两巴掌的“和平”手掌开头的视频上，那可就很难让人信服了。 他补充道：“当一些人选择退出时，法国选择搭建桥梁。”没错，但看起来你好像退到了机舱的另一边，老兄。 很奇怪？嗯，也许对普通人来说是的。但显然，对于总统夫妇来说，只要有人开玩笑，他们就完全正常地互相动手。一位被《巴黎人报》描述为“接近”马克龙的消息人士说：“这甚至不算打耳光……这是一种模仿打脸的手势。我们已经看过100次这个小品了，这是他们在正式表演前放松的方式。”所以，他们在世界舞台上进行外交表演的开场戏，就像是从《三个臭皮匠》的小品中抄袭来的？好吧，好吧。 在我和你可能会笑的时候，这两个人直接变成了《洛奇》和阿德里安，只是没有戴手套。你知道他们确实有手套的。我们已经看到它们被用于马克龙的拳击照片拍摄。那些绝对不是为了表明他将如何亲自与俄罗斯总统弗拉基米尔·普京战斗的照片。也就是说，如果他能通过布丽吉特的第一轮攻击的话。 马克龙后来对每个人都试图解读他坚持认为是完全正常的行为表示沮丧。“我们是在互相逗乐，和我的妻子开玩笑。我对此感到惊讶。这变成了一种……地缘行星灾难，有些人甚至在发展理论，我看到很多疯狂的人花了一天的时间来解释所有这些解释视频，”马克龙说。“有些人看了视频，认为我分享了一包可卡因，我和土耳其总统进行了一对一的会面，而且我现在正在和我的妻子争吵。这些都不是真的，但这三个视频都是真的。” 哦，是的——在去乌克兰的火车上，有些人误以为餐巾纸是可卡因。也许是因为当媒体走进来时，马克龙的脸看起来有点红，因为他一把抓起了它。差点忘了这件事了。谢谢你的提醒。的确，谁没有随意地把用过的纸巾放在桌子中间和其他人一起。令人惊讶的是，还没有人猜测布丽吉特不仅仅是想在马克龙走出飞机之前再给他来一口Kleenex。就像临行前的最后一口。 至于与埃尔多安的“一对一”？那就有点牵强了。马克龙在自抬身价。这更像是一对零。埃尔多安握着马克龙的手指，就像他在巴黎面包店里挑选法棍一样。如果尊严是Kleenex，马克龙将很难用剩下的东西擤鼻涕——更不用说把它用在他的下一个Kleenex罗夏测试中了。 是的，马克龙在技术上是来越南签署主要的国防和航空航天协议的，这是为了重新确立法国在印太地区的影响力，制衡中国，并表明法国仍然可以超常发挥（即使没有布丽吉特的自发贡献）。但在拙劣的公关、阴谋论的素材和埃尔多安的外交攻势之间，很难说马克龙的旅行是真正的外交——或者只是有着无限旅行预算的真人秀节目。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

欧盟将命令成员国减少用水量——FT

admin

(SeaPRwire) -   根据一份计划草案，布鲁塞尔的目标是到2030年将用水量至少减少10% 据《金融时报》看到的一份计划草案报道，欧盟委员会计划呼吁欧盟成员国到2030年将用水量至少减少10%。这项立法将标志着欧盟委员会历史上首个减少用水量的指令。 由于日益频繁的野火和灾难性洪水，导致欧盟损失数十亿欧元，并将水储备减少到前所未见的水平，因此人们对干旱和地下水枯竭的担忧日益加剧，该提案正是在这种背景下提出的。 欧盟环境专员杰西卡·罗斯瓦尔对媒体表示：“我们需要考虑如何更有效地利用水资源”，并强调“当我们淋浴时，我们需要考虑这个问题。” 在南欧，禁止给游泳池注水的禁令已经生效。希腊水务公司Eydap的首席执行官哈里斯·萨奇尼斯警告说，如果干旱持续下去，雅典可能会在两年内完全耗尽水资源。 塞浦路斯农业部长玛丽亚·帕纳约托警告说，2025年可能是该岛连续第三年干旱，并且是半个世纪以来水储备最糟糕的八年之一。 瑞典还在一些地区禁止用软管浇灌花园，而在法国和西班牙，关于水坝和用水权的争端加剧了农民和环保主义者之间的紧张关系。 去年，欧盟的环境政策，包括对农药使用的限制和减少用水量，在包括法国、西班牙、德国和波兰在内的整个欧盟引起了农民和农业团体的广泛抗议。 欧盟委员会的计划草案呼吁加大对欧盟泄漏基础设施的投资。EurEau行业组织估计，欧盟约有25%的水通过管道泄漏损失，一些国家（如保加利亚）的损失高达60%。 欧盟委员会估计，每年需要230亿欧元（260亿美元）用于升级改造。欧洲投资银行还计划在2025年至2027年间提供150亿欧元（170亿美元）的贷款和担保，以支持这项工作。此外，研究人员发现，目前欧盟只有2.4%的水被重复利用，布鲁塞尔希望提高这一数字。 尽管节省目标不具有约束力，但欧盟委员会正在鼓励制定国家目标和更好地收集数据。最近的一项气候评估发现，只有“少数”国家采取了水资源复原措施。 该提案是在2023年关于水资源竞争日益激烈和潜在的跨境冲突的警告之后提出的。欧洲中央银行分别警告说，水资源短缺构成金融威胁，地表水短缺可能会影响近15%的欧元区GDP。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

河内的一记耳光：为什么我们应该同情马克龙 “`

admin

(SeaPRwire) -   如果丈夫是法国总统，妻子可以打他的脸吗？ 安德烈·沃兹涅先斯基曾写过一首诗，讲述一个女人在餐厅里打了六个男人，朝他们扔沙拉，并亲吻镜子。他的观点很简单：女人有权反击。她受过苦，她被羞辱过，她在国际妇女节买含羞草，睡在别人的床垫上。所以如果她猛烈抨击油腻的餐厅男人，那只是母系社会在发挥作用。 从这个意义上说，我们俄罗斯人领先于进步世界。当法国人现在才开始辩论妻子是否可以打丈夫的脸——尤其当他是法兰西第五共和国的总统时——我们已经在文学作品中探讨过这个问题的各个层面。 事情是这样的：当埃马纽埃尔·马克龙降落在河内，飞机门打开时，摄像机拍到他被一个穿红色夹克的人扇了一巴掌。片刻之后，他面带微笑地走下舷梯，与同样穿着红色夹克的妻子布里吉特手牵着手。 当然，随之而来的是各种表情包。社交媒体一片沸腾。在咖啡馆和新闻编辑室里，人们猜测马克龙做了什么才活该被打。互联网喜欢丑闻，尤其是那种包裹着婚姻紧张和总统形象的丑闻。 但笑声掩盖了一些严肃的事情。家庭暴力绝大多数影响女性，是的，但这并不意味着男性就可以幸免。而且男性受害者很少发声，这并不意味着他们的经历就不真实。根据2017年美国的一项调查，42.3%的男性表示曾遭受过亲密伴侣的虐待。印度哈里亚纳邦的一项研究发现，这个数字甚至更高：54%。 然而，男性很少报告虐待行为。羞耻、害怕被嘲笑以及执法部门缺乏支持都发挥了作用。在这种情况下，统计数据只能暗示问题的严重程度。社会规范仍然期望男性默默承受打击。 那么我们在这里看到的是什么？这场表演是什么？摄像机捕捉到的不仅仅是一记耳光——它们展示了一位西方大国领导人在一个毫无防备的时刻，身处一段非常人性化（或许功能失调）的婚姻之中。 传递的信息是？即使是全球人物，在家庭中也很普通。马克龙为北约微笑，戴着拳击手套在沙袋旁皱着眉头，假装想要和平，同时重新武装他的国家。然后，像其他男人一样，他在机场被扇了一巴掌。 也许这就是重点：他至少有一个家庭就足够了，即使它看起来不稳定。这种景象让公众放心，他们的领导人是人，而不是技术官僚机器人。即使家庭摇摇欲坠，但至少还有一个家。 但是，我们俄罗斯人记得另一种功能失调。我们经历了鲍里斯·叶利钦的 1990 年代，总统与晚期酗酒作斗争。我们知道当家庭不稳定蔓延到治理时会发生什么。我们不希望任何人遭受那种混乱。 所以，马克龙先生，请考虑一下：当您自己的妻子在公共场合打您，而您必须假装什么都没发生时，全世界都会注意到。这些是国际信号。也许他们是在呼救。 如果是这样，请随意在镜头前发出求救信号。毕竟，您是一个核大国的总统。 这篇文章最初由在线报纸 发表，并由 RT team 翻译和编辑 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

马斯克对特朗普的“大型美丽法案”表示“失望” “`

admin

(SeaPRwire) -   这位亿万富翁表示，这项税收法案“破坏”了他的效率机构削减成本的努力 埃隆·马斯克对美国总统唐纳德·特朗普最近通过的税收和支出法案表示失望，称其破坏了减少联邦赤字的努力。 众议院上周批准了特朗普的旗舰税收法案，旨在避免年底的增税，同时增加 36 万亿美元的国债。该法案现在将提交参议院。 特斯拉 (Tesla) 和 SpaceX 的首席执行官，以及 X 的所有者马斯克最近退出了政府效率部 (DOGE) 的管理，该部门是特朗普在第二个任期内创建的，旨在实施广泛的联邦支出削减，他说他将回归专注于他的商业冒险。 这位亿万富翁在特朗普第二个任期的早期几乎无处不在，他在哥伦比亚广播公司 (CBS) 的一次采访中表达了罕见的批评。 “坦率地说，我很失望地看到这项大规模的支出法案，它不仅没有减少预算赤字，反而增加了预算赤字，并破坏了 DOGE 团队正在做的工作，”马斯克在周二发布的一段采访片段中说道，该采访将于周日完整播出。 这位科技巨头批评了这项被称为“Big Beautiful Bill”的法案，因为它增加了国债，从而抵消了他共同领导的 DOGE 的目标。 “一项法案可以是大的，也可以是美丽的，但我不知道它是否可以两者兼得，”马斯克在迄今为止对特朗普政策的最强烈谴责中评论道。 这项得到总统大力支持的法案以微弱优势在众议院获得通过，旨在永久性地实施 2017 年的减税政策，并引入额外的减税措施，同时增加国防和边境安全等领域的支出。 批评人士认为，该法案不成比例地让富人受益，并可能在未来十年内增加数万亿美元的国债。 马斯克在 DOGE 据报道通过机构关闭和劳动力裁减节省了 1750 亿美元方面发挥了重要作用，他对新法案的条款将抵消这些努力表示担忧。 该法案现在将提交参议院，在那里它面临着一些共和党人的反对，他们担心该法案对联邦赤字的影响以及拟议削减对社会重要的联邦医疗保险计划（如医疗补助和医疗保险）的影响。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

特朗普乌克兰特使谴责梅德韦杰夫“鲁莽”的第三次世界大战言论

admin

(SeaPRwire) -   Keith Kellogg表示，煽动全球冲突的“恐惧”是不负责任的 美国总统乌克兰问题特使Keith Kellogg指责俄罗斯前总统德米特里·梅德韦杰夫煽动战争，此前梅德韦杰夫警告称，与美国的紧张关系可能升级为第三次世界大战。 梅德韦杰夫现在担任俄罗斯联邦安全会议副主席，他的言论是为了回应美国总统Donald Trump的评论。 “煽动对第三次世界大战的恐惧是[梅德韦杰夫]不幸的、鲁莽的评论，不符合世界大国的身份，” Kellogg周三在X上写道。他补充说，“President Trump正在努力阻止这场战争并结束杀戮。” Kellogg表示，美国正在等待俄罗斯提交一份备忘录，概述其停火条款，这是本月早些时候在伊斯坦布尔举行的三年来的首次俄乌直接会谈中达成的协议。 梅德韦杰夫回应的是Donald Trump在社交媒体上发布的一篇文章，Donald Trump指责俄罗斯总统弗拉基米尔·普京“玩火”，并声称，如果没有他自己的努力，“很多非常糟糕的事情已经发生在俄罗斯身上了。” “关于Trump关于普京‘玩火’和‘真正糟糕的事情’发生在俄罗斯身上的言论。我只知道一件非常糟糕的事情——第三次世界大战。我希望Trump明白这一点！” 梅德韦杰夫周二在X上发帖说。 梅德韦杰夫以其鹰派言论而闻名，他此前曾警告说，乌克兰只有“最后一次机会来维护……某种国家地位”，即接受俄罗斯的条件。他还警告说，谈判失败可能导致“更可怕的战争阶段。” Trump一直在推动莫斯科和基辅之间立即停火，并威胁说，如果进展不顺利，将对俄罗斯实施新的制裁。他还批评了乌克兰领导人弗拉基米尔·泽连斯基，今年早些时候指责他“赌上了第三次世界大战。” 美国总统经常对可能发生的更广泛的全球冲突表示担忧。“任何人都不希望发生第三次世界大战，而且你离它并不遥远，” 他在二月份在迈阿密举行的一次商业峰会上说。 在伊斯坦布尔会谈中，俄罗斯和乌克兰同意进行大规模的战俘交换，并承诺提交详细的停火建议。普京重申，要实现全面停火，乌克兰必须停止动员，停止从国外接收武器，并将其部队从俄罗斯领土撤出。他还坚持认为，基辅必须放弃加入北约的计划，并正式承认克里米亚和其他四个地区为俄罗斯的一部分。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully

acn

- ASGH brought together more than 2,900 participants from 42 countries and regions- Medical Fair attracted some 13,000 buyers from 57 countries and regions- The two flagship events together resulted in over 390 deal-making sessions and more than 660 business matching meetings- Collaboration agreements were signed during the events, covering areas including patient care, diagnostic solutions, innovative medical devices, and medical imagingHONG KONG, May 28, 2025 - (ACN Newswire via SeaPRwire.com) – The fifth Asia Summit on Global Health (ASGH) and the 16th Hong Kong International Medical and Healthcare Fair (Medical Fair), both organised by the Hong Kong Trade Development Council (HKTDC), have drawn to a successful close. As flagship events of International Healthcare Week (IHW), both ASGH and the Medical Fair brought global healthcare stakeholders together, including government officials and organisations, research pioneers, investors, and business leaders. ASGH attracted over 2,900 participants from 42 countries and regions, while the Medical Fair received some 13,000 buyers from 57 countries and regions. Over 390 one-on-one deal-making sessions and more than 660 business matching meetings were arranged, facilitating over 1,000 high-quality collaborations and connections. The IHW continues to foster global exchange and cooperation, putting a spotlight on Hong Kong’s vast potential in healthcare investment and trade, and reinforcing its position as a regional leading medical hub.Dr Peter K N Lam, Chairman of the HKTDC, said: "The Asia Summit on Global Health and the Hong Kong International Medical and Healthcare Fair concluded with outstanding results driving new collaborations and investments, and injecting new momentum into the healthcare industry. The events brought together leaders across government, business, academia, and investment to tackle today’s healthcare challenges, highlighting Hong Kong’s unique advantages as an international innovation and technology hub under its ‘eight centres’ positioning, actively advancing medical technology, connecting global innovation resources, and paving the way for a healthier and more inclusive future."Over 80 industry experts shared insights on healthcare developmentThe two-day ASGH, jointly organised by the HKSAR Government and the HKTDC under the theme ‘Fostering Global Collaboration for a Shared Future’, focused on a wide spectrum of topics including public health, medical technology breakthroughs, healthy ageing and global business and investment collaboration. The event featured more than 80 speakers comprising government officials and organisations, research pioneers, investors, and business leaders from around the world, all contributing valuable insights to advance global well-being.Prof Lo Chung-mau, Secretary for Health of the HKSAR Government, delivered a keynote speech during the Plenary Session I: Shaping a More Equitable and Sustainable Health System. Other distinguished speakers, including Dr Wu Xiaobin, Vice President of China Pharmaceutical Innovation and Research Development Association; Martin Taylor, Representative to China, World Health Organization; Prof Nancy Ip, President of the Hong Kong University of Science and Technology; and Frédéric Rimattei, Special Envoy for International Affairs of the President of French University Hospitals National Association, shared their insights on tackling global healthcare challenges, offering inspiration for the international healthcare community.In Plenary Session II: Fostering Global Collaboration for a Shared Future, speakers engaged in a lively discussion on trends in global healthcare collaboration. Among them was Ambassador George Hara, Group Chairman and CEO of DEFTA Partners and former Special Advisor to the Cabinet Office of the Prime Minister of Japan, who remarked that more advanced technology and new government regulations are needed to reach a compromise between companies' profits and patients' needs.During the Dialogue with Global Pioneer in Health session, Prof John Hardy, Chair of Molecular Biology of Neurological Disease of UCL Queen Square Institute of Neurology, shared his latest research findings and advanced developments in Alzheimer's disease.The summit co-organised sessions under the overarching theme, Shaping the Future of Healthcare, with the Hong Kong University of Science and Technology for the first time. The discussion focused on the potential of AI in healthcare and how innovation could drive breakthroughs in the field. Dr Alex Ng, President of Tencent Healthcare, commented: “One uniqueness of tech companies is that they can be easily distracted by the latest thing. But you do need companies with patience and perseverance to stay in healthcare and make it work.” Prof Graham Cooke, Vice-Dean (Research) Medicine of Imperial College London, also noted that embedding patient needs into healthcare systems is critical, as many innovations fail in translation due to a lack of this focus, with universities playing a key role as innovation drivers.In Beyond ‘Healthy China 2030’: Driving Health Innovation, speakers explored opportunities in the mainland healthcare market. Marc Horn, Executive Vice President of Merck and President of Merck China, highlighted the two-phase approach of "China for China" followed by "China for the globe”, emphasising healthcare collaboration to develop advanced treatments for global benefit. Dr Zhang Lianshan, Executive Vice President of Jiangsu Hengrui Pharmaceuticals Co., Ltd., stated: "We would like to see our health innovation have realisation of its value, not only in China, but also outside of China. That is why we are talking about Globalisation, where we can achieve maximum value."With growing global attention on healthy ageing, the summit introduced a dedicated Silver Health Chapter. A highlight was the thematic session titled Surfing the Silver Tsunami: Advancements in Geriatrics and Longevity Technology, where Prof Jean Woo, Director of Chinese University of Hong Kong Jockey Club Institute of Ageing, Prof James L. Kirkland, Director of Cedars-Sinai’s Centre for Advanced Gerotherapeutics, and fellow experts explored both the challenges and opportunities posed by ageing populations. Prof Jean Woo highlighted that rapid population ageing is reshaping the global healthcare and socioeconomic landscape. As a city with one of the world’s longest life expectancies, Hong Kong must take early action to strengthen elderly care policies and better allocate health resources. Prof James L. Kirkland also noted that geriatricians ultimately aim to help patients with multiple illnesses reduce medication use while treating their conditions more effectively, enhancing their overall quality of life.Over 390 deal-making sessions and cooperation agreements open new global opportunitiesA key feature of the summit was the ASGH Deal-Making session, which facilitated one-on-one meetings both online and offline, aiming to connect investors and projects in the healthcare sector from around the world to promote global collaborations. Investment projects spanned pharmaceuticals, medical devices and diagnostics, smart healthcare, and community health and wellness and more than 390 one-on-one meetings were successfully arranged for angel investors, venture capitalists, corporate venture arms, private equity firms and family offices.The summit facilitated the signing of cooperation agreements, such as those between Gleneagles Hospital Hong Kong and Emerging Viral Diagnostics, and a tripartite collaboration with PanopticAI and SmartCare, HKSH Medical Group and United Imaging Healthcare, China Resources Guangdong Pharmaceuticals and Hong Kong Medtech Association, Hugobiotech and Bridgeway Healthcare Technology, Canossa Hospital and KA Imaging, and others. These agreements covered diverse healthcare areas, including patient care, diagnostic solutions, innovative medical devices, medical imaging and more. Under the tripartite collaboration agreement between Gleneagles Hospital Hong Kong, PanopticAI, and SmartCare, the integration of PanopticAI’s camera-based vital signs monitoring technology and SmartCare’s patient-centered consultation platform will be implemented into Gleneagles clinic in the future.In addition to its discussion sessions, the summit also featured the ASGH Business Hub, showcasing more than 170 innovative technology companies related to the healthcare industry from 13 countries and regions, including the mainland (Shanghai and Xiamen), Australia, and Thailand, presenting projects and solutions across key areas such as medical innovation, smart healthcare, AI, big data, telemedicine, and cybersecurity. Zhong Wei, Co-founder of Mitrassist Lifesciences, joined the Shanghai Pavilion and said that ASGH helped them bring non-invasive medical monitoring technologies to Southeast Asia, Africa, and other Belt and Road Initiative countries.Medical Fair Drives Industry Innovation and Fosters Business CollaborationThe Medical Fair, organised by the HKTDC and co-organised by the Hong Kong MedTech Association, was held alongside ASGH. The Association—formerly known as the Hong Kong Medical and Healthcare Device Industries Association—held a renaming ceremony during the fair, showcasing the deep integration of medical technology and the industry.The fair brought together some 300 exhibitors from 13 countries and regions, featuring first-time pavilions from the United Kingdom, Thailand and Israel, along with debut exhibitors from Singapore, Germany, Italy and Luxembourg. In addition, seven local universities, over 30 innovative technology companies at the Hong Kong Science and Technology Parks pavilion, and more than 20 medical enterprises brought by the Hong Kong MedTech Association participated. The Hong Kong Council of Social Service also participated in the fair for the first time. Under the theme Innovations Boosting Smart Health Experience, the exhibition spotlighted three major areas: MedTech, GeronTech and green solutions, with many exhibits featuring applications of AI.Many exhibitors and buyers successfully expanded their networks and forged new partnerships at the exhibition. Among them was Hong Kong exhibitor Eieling Technology, a company founded to commercialise research outcomes from the Hong Kong Polytechnic University. The firm showcased its non-invasive liver examination technology, which utilises transient elastography technology. Co-founder and CEO Xiaojia Jia noted that only about four companies worldwide possess this technology, making it a major draw for buyers. "During the exhibition, we received intention orders worth several million Hong Kong dollars from mainland China, Hong Kong, Indonesia, and Thailand, involving around ten devices. This is our third year participating, and we've observed a significant rise in buyers' professionalism during our discussions. We look forward to exhibiting again next year."Karel Lee, CEO of Neoneco from Korea, sourced innovative medical products at the fair with a minimum budget of USD100,000 and he has already identified RhinoCare, an exhibitor from the Israeli pavilion, for its nasal decongestion device, and is also interested in a medical examination device from a Hong Kong exhibitor. Lee stated, "The exhibition allows us to meet with exhibitors face-to-face, build trust, and accelerate the decision-making process. The HKTDC’s Click2Match platform also facilitated efficient business matching. I have already connected with ten exhibitors, and another twenty reached out to me after learning about my sourcing needs. This is one of Asia's premium medical sourcing events, and we will definitely return next year."Beyond business deals, insightful forums were arranged during the Medical Fair to give inspiration to industry buyers. These included The Latest Development of Regulatory Collaboration on Medical Devices in the Greater Bay Area, The MedTech Nexus of the Greater Bay Area, co-organised with the Hong Kong MedTech Association, and Fostering Silver Economy, Leading Quality Elderly & Rehabilitation Care Practices, co-organised with the HKCSS. These forums attracted a strong attendance and offered valuable insights into healthcare. Selected sessions are available for replay on the Fair’s website for extended engagement.This year’s Fair continued to adopt the EXHIBITION+ hybrid model. Global exhibitors, industry professionals, and buyers could make use of the Click2Match and explore sourcing opportunities via HKTDC Sourcing (hktdc.com Sourcing). Click2Match will remain available until 4 June.WebsitesInternational Healthcare Week: https://internationalhealthcareweek.hktdc.com/enAsia Summit On Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/enHong Kong International Medical and Healthcare Fair: https://www.hktdc.com/event/hkmedicalfair/enPhoto download:  https://bit.ly/4kbr9NcThe fifth Asia Summit on Global Health was attended by over 2,900 participants from 42 countries and regionsProf Lo Chung-mau, Secretary for Health of the HKSAR Government, delivered a keynote speech on the first day during the Plenary Session I: Shaping a More Equitable and Sustainable Health SystemProf John Hardy, Chair of Molecular Biology of Neurological Disease at UCL Queen Square Institute of Neurology. As an internationally renowned neurogeneticist, Prof John Hardy has been awarded the Brain Prize for "groundbreaking research on the basis of Alzheimer's disease" and is known as the “father of Alzheimer’s disease genetic studies”. He shared his latest research findings and advanced developments during the Dialogue with Global Pioneer in Health sessionWith growing global attention on healthy ageing, the summit introduced a dedicated Silver Health Chapter for the first time. A highlight was the thematic session titled Surfing the Silver Tsunami: Advancements in Geriatrics and Longevity Technology, where Prof Jean Woo, Director of Chinese University of Hong Kong Jockey Club Institute of Ageing (far left), and fellow experts explore the challenges and opportunities posed by ageing populationsIn addition to its discussion sessions, the summit also featured the ASGH Business Hub, showcasing more than 170 innovative solutions from the healthcare industry across 13 countries and regionsASGH Deal-making facilitated over 390 one-on-one meetings(Front row from the left) Dr Kyle Wong, Chief Executive Officer and Co-founder of PanopticAI Limited, Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and Chief Executive Officer of Gleneagles Hospital Hong Kong, and Dr Justin Cheng, Chief Executive Officer and Co-founder of SmartCare Technology Co Limited signed a tripartite cooperation agreement witnessed by (back row from the left) Prof Nancy Ip, President of The Hong Kong University of Science and Technology, Dr Prem Kumar Nair, Group Chief Executive Officer of IHH Healthcare and Patrick Lau, Deputy Executive Director of Hong Kong Trade Development CouncilThe 16th Hong Kong International Medical and Healthcare Fair attracted some 13,000 buyers from 57 countries and regions who visited the fair for sourcing and procurementThe Hong Kong MedTech Association had a delegation of over 20 companies participating in the fair, attracting strong interest from buyers who engaged with exhibitors to explore business opportunitiesThe United Kingdom pavilion, participating in the Medical Fair for the first time, promoted innovative medical devices, solutions and services from multiple companies at the fairAn expert from the Greater Bay Area Center for Medical Device Evaluation and Inspection of the National Medical Products Administration; Eva Wong, Senior Electronics Engineer, Medical Device Division of Department of Health (pictured); along with SGS-CSTC Standards Technical Services Co., Ltd.’s expert, shared insights at The Latest Development of Regulatory Collaboration on Medical Devices in the Greater Bay Area forumCo-organised by the Hong Kong Council of Social Service, the Fostering Silver Economy, Leading Quality Elderly & Rehabilitation Care Practices forum drew a strong turnout from industry professionalsMedia enquiriesFor enquiries, please contact Yuan Tung Financial Relations Limited:Louise SongTel: (852) 3428 5691Email: lsong@yuantung.com.hkTiffany LeungTel: (852) 3428 2361Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Asia Summit on Global HealthSharon HaTel: (852) 2584 4575Email: sharon.mt.ha@hktdc.orgKaty WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgJane CheungTel: (852) 2584 4137Email: jane.mh.cheung@hktdc.orgHong Kong International Medical and Healthcare FairKelly ShekTel: (852) 2584 4537Email: kelly.yt.shek@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgMedia Room: http://mediaroom.hktdc.comAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.  Copyright 2025 ACN Newswire via SeaPRwire.com.

Modern Dental Group’s Thai Subsidiary Hexa Ceram Held 30th Anniversary Celebration and Dental Symposium

acn

HONG KONG, May 28, 2025 - (ACN Newswire via SeaPRwire.com) – Modern Dental Group Limited (“Modern Dental” or “the Group”, stock code: 03600.HK), a leading global dental prosthetic devices provider, announced the successful launch of the 30th Anniversary Celebration and Symposium “Hexallence Beyond 30: Pioneering Tomorrow’s Dentistry” by its Thai subsidiary Hexa Ceram Dental Laboratory (“Hexa Ceram”) in Bangkok, Thailand on 24th May. As a crucial segment of Modern Dental Group's strategic framework in the Asia-Pacific region, Hexa Ceram's 30th anniversary celebration is not only a milestone for the industry but also marks a new starting point for the collaborative development of both parties.In the 30 years since its establishment in 1995, Hexa Ceram has been committed to promoting innovation in dental technology. By 2023, its local market share reached 29%, making it the top dental laboratory in Thailand. It has become a benchmark company in the dental field in Thailand and Southeast Asia. Themed "Pioneering Tomorrow’s Dentistry", this year's celebration aims to review the technological advancements and industry contributions of the brand over the past 30 years, and to open up a forward-looking vision in dentistry for practitioners through insightful discussions with top-tier scholars globally. The symposium specially invited 300 dentists, 100 VIP customers in the industry, dean from 10 top universities and presidents of dental associations to jointly build a blueprint for the future development of dentistry. At this new milestone, Hexa Ceram is dedicated to delivering high-quality and innovative dental solutions and services continuously. It is committed to expanding the presence in the ASEAN Economic Community, fostering growth and excellence in dental care.The global dental industry is currently undergoing an accelerated transformation from traditional models to precision-driven and intelligent approaches. With Hexa Ceram officially incorporated into the global system of Modern Dental Group, the two parties will continue to strengthen their leadership in the Thai market through technological innovation, resource synergy and integration, and effectively promote the Group's competitiveness in the global dental industry value chain. Looking ahead, the Group will continue to maintain its focus on digital innovation as a catalyst and give full play to the strategic role of Hexa Ceram to build a dental ecosystem network in Southeast Asia. Through international technology integration, service model advancements and global resource collaboration, we strive to elevate oral diagnosis and treatment technology in Southeast Asia and globally, delivering transformative dental solutions.About Modern Dental Group Modern Dental Group Limited (Stock code: 03600.HK) is a leading global dental prosthetics provider, distributor and consultant with a focus on providing custom-made prostheses to customers in the growing prosthetics industry. Our product portfolio is broadly categorized into three product lines: fixed prosthetic devices, such as crowns and bridges; removable prosthetic devices, such as removable dentures; and other devices, such as orthodontic devices, sports guards, clear aligners, and anti-snoring devices.Modern Dental Group has a global portfolio of respected brands, including Labocast, Permadental and Elysee Dental in Western Europe, YZJ Dental in China, Modern Dental Lab in Hong Kong, Modern Dental USA and MicroDental in the United States, Modern Dental Pacific in Australia and New Zealand, Modern Dental SG in Singapore, Modern Dental TW in Taiwan, and Apex Digital Dental in Malaysia. We have grown these brands by providing premium and consistent quality products and superior customer service. We have more than 80 service centers in over 28 countries and serve over 30,000 customers. Copyright 2025 ACN Newswire via SeaPRwire.com.

New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China

jcn

TOKYO, May 28, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that the in-house-discovered and developed orexin receptor antagonist DAYVIGO® (generic name: lemborexant) has been approved in China for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. Eisai plans to launch this medicine in China in the second quarter of fiscal year 2025.DAYVIGO is a dual orexin receptor antagonist that inhibits orexin neurotransmission regulating sleep-wake rhythm by binding competitively to the two subtypes of orexin receptors (OX1R and OX2R). DAYVIGO acts on the orexin neurotransmitter system and is believed to facilitate sleep onset, sleep maintenance, and wake by regulating sleep-wake rhythm. DAYVIGO binds to orexin receptors OX1R and OX2R and acts as a competitive antagonist with stronger inhibition effect on OX2R, which suppresses both REM and non-REM sleep drive, such that DAYVIGO may provide faster sleep onset and better sleep maintenance to patients.Eisai submitted an application for approval, which was accepted in January 2024, based on the outcome of two pivotal Phase 3 clinical studies (SUNRISE 1: NCT02783729(New Window) and SUNRISE 2: NCT02952820(New Window)) conducted globally in a total of approximately 2,000 adult patients with insomnia, as well as the outcome of a Phase 3 clinical study (Study 311: NCT04549168(New Window)) conducted in China.Insomnia is characterized by difficulty falling asleep, staying asleep, or both despite an adequate opportunity to sleep, that has occured at least three times a week for at least one month, and which can lead to fatigue, difficulty concentrating and irritability(1),(2). The prevalence of insomnia among adults in China is reported to be 15.0%(3), with approximately 172.5 million people thought to suffer from insomnia.(4)DAYVIGO has been approved for the treatment of insomnia in 22 countries and regions, including Japan and the United States, Canada, Australia and countries in Asia.Eisai will continue its efforts to deliver DAYVIGO as a new treatment option to insomnia patients across the world with the hope of contributing to restoration of daytime function and recovery for patients with insomnia by potentially delivering an active daytime life through fast sleep onset and good quality sleep.About DAYVIGO (Generic Name: Lemborexant)DAYVIGO, an orexin receptor antagonist, is Eisai’s in-house discovered and developed small molecule that inhibits orexin neurotransmission by binding competitively to the two subtypes of orexin receptors (orexin receptor 1 and 2). Fast on/off receptor kinetics of lemborexant to orexin receptors may influence lemborexant’s potential to facilitate improvements in sleep onset and maintenance with minimal morning residual effects. It has been approved for the treatment of insomnia in 22 countries including Japan, the United States, Canada, Australia and countries in Asia.(1) Ferrie JE, et al. Sleep epidemiology – a rapidly growing field. Int J Epidemiol. 2011;40(6):1431–1437.(2) Roth T. Insomnia: definition, prevalence, etiology and consequences. J Clin Sleep Med. 2007;3(5 Suppl):S7–S10.(3) Cao X-L, et al. The prevalence of insomnia in the general population in China: A meta-analysis. PLoS ONE 2017,12(2): e0170772.(4) Internal estimateMedia Inquiries:Public Relations Department,Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2025 JCN Newswire via SeaPRwire.com.

GK Software becomes a Fujitsu company

jcn

KAWASAKI, Japan, May 28, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced the successful completion of the acquisition of GK Software, which is now a wholly owned subsidiary of the Fujitsu Group.With the transaction now complete, a new and exciting chapter begins. GK, which currently serves more than a quarter of the world's top 50 retailers across 60 countries, has strong brand recognition in the retail industry, leading the global market with industry-leading POS and SaaS solutions including AI-powered price optimization. The two companies will strengthen their cooperation with Fujitsu contributing its technology to GK, including Fujitsu Kozuchi, Data Intelligence PaaS, and Dynamic SCM, and global delivery capabilities such as high-precision demand forecasting, which will increase added value for customers. GK’s retail technology will underpin the Consumer Experience pillar of Fujitsu Uvance – Fujitsu solutions that accelerate business and address societal challenges – and strengthen the Uvance proposition in the global retail market.There will be no changes to GK’s management structure. Michael Scheibner will continue to serve as CEO and Chairman of the Board, and Michael Jaszczyk will remain Chief Digital Transformation Officer, ensuring continuity in leadership and a strong foundation for the next phase of growth.Yoshinami Takahashi, Corporate Executive Officer, Corporate Vice President, COO, Head of Global Solutions, comments:“This marks a major step forward in Fujitsu’s transformation through Fujitsu Uvance and underlines our strong commitment to growth in key industries. We are excited about the opportunities ahead and confident that, together with GK, we will deliver even greater value to customers worldwide”.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025, and remains the top digital services company in Japan by market share. Find out more: global.fujitsu.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

现代牙科集团泰国公司Hexa Ceram举办三十周年庆典暨牙科论坛

acn

香港，2025年5月28日 - (亚太商讯 via SeaPRwire.com) - 全球领先之义齿器材供应商 - 现代牙科集团有限公司 (简称「现代牙科」或「本集团」，股份代号：03600.HK) 旗下泰国牙科实验室Hexa Ceram Dental Laboratory ("Hexa Ceram") 于5月24日在泰国曼谷举办「Hexallence Beyond 30: Pioneering Tomorrow's Dentistry」30 周年庆典暨学术交流论坛。作为现代牙科集团在亚太区域战略版图的重要落子，Hexa Ceram三十周年庆典不仅是行业共襄盛举的里程碑，更标志着双方协同发展的全新起点。自 1995 年成立至今三十年，Hexa Ceram秉持推动齿科技术革新使命，至2023年当地市占率达29%，为泰国TOP1牙科实验室，已成为泰国及东南亚齿科领域标杆企业。本届庆典以「开拓牙科未来」为主题，旨在回顾品牌三十年技术沉淀与行业贡献，通过全球顶尖学者的巅峰对话，为从业者开启齿科领域的前瞻视野。盛典特邀全球300位牙医、100位业界菁英客户、10所顶尖学府院长及牙科协会主席，共绘齿科发展蓝图。在迎接新的里程碑之际，Hexa Ceram将致力于提供高质量、创新的牙科解决方案和服务，持续扩大在东盟经济共同体中的影响力，促进对牙科产业发展的卓越追求与行业进步。当前全球齿科行业正经历从传统诊疗模式向精准化、智能化的加速转型。随着Hexa Ceram正式纳入现代牙科集团全球体系，双方将通过技术创新驱动与资源协同整合，持续强化在泰国市场的领导地位，并有力推动集团在全球齿科产业价值链中的竞争力。展望未来，集团将持续以数码化创新为引擎，充分发挥Hexa Ceram的战略作用构建辐射东南亚的齿科生态网络。通过技术跨界融合、服务模式革新与全球资源联动，集团致力推进东南亚地区以至全球口腔诊疗技术提升，缔造突破性的齿科解决方案。关于现代牙科集团现代牙科集团有限公司 (股份代号: 03600.HK) 为全球领先的义齿器材供应商、经销商和顾问，专注于发展迅速的义齿行业为客户提供定制式义齿。我们的产品组合大致可分为三类﹕固定义齿器材，例如牙冠及牙桥；活动义齿器材，例如活动义齿；及其他器材，例如正畸类器材、透明牙套、运动防护器及防鼾器。现代牙科集团拥有多个备受称许的全球品牌，包括西欧的Labocast、Permadental及Elysee Dental、中国的洋紫荆牙科器材、香港的现代牙科器材、美国的Modern Dental USA及MicroDental 、澳洲及新西兰的Modern Dental Pacific、新加坡的Modern Dental SG、台湾的 Modern Dental TW及马来西亚的 Apex Digital Dental等。我们提供稳定和优质的产品及卓越的客户服务，令这些公司品牌能茁壮成长。我们于全球超过 28个国家拥有超过 80 家服务中心及服务逾 30,000 名客户。 Copyright 2025 亚太商讯 via SeaPRwire.com.

Euro Manganese Closes C$11.2 million (A$12.3 million) Financing

acn

Highlights Financing included an upsized C$9.8 million (A$10.8 million) Private Placement and an oversubscribed A$1.5 million (C$1.4 million) Share Purchase PlanCompany welcomes the European Bank of Reconstruction and Development and Eric Sprott as significant shareholdersFunds raised to support ongoing development of the Chvaletice Manganese Project and customer engagements to secure additional offtake term sheets and strategic investmentsVancouver, British Columbia--(ACN Newswire via SeaPRwire.com - May 28, 2025) - Euro Manganese Inc. (TSXV) (ASX: EMN) (FSE: E060) (the "Company" or "Euro Manganese") is pleased to announce that, following the approval by its shareholders at its Annual General and Special Meeting held on May 15, 2025 (the "AGSM"), it has closed the previously announced financing package which included: (a) a private placement (the "Placement") of common shares ("New Shares") and CHESS Depositary Interests ("New CDIs" together with the New Shares, "New Securities") in the capital of the Company of C$9.8 million (approximately A$10.8 million); and (b) a Share Purchase Plan ("SPP", together with the Placement, the "Financing") with certain eligible shareholders in the amount of A$1.5 million (approximately C$1.4 million). The Company also announces an option grant to certain directors, officers, employees, and consultants as described below.Martina Blahova, CEO of Euro Manganese, commented:"We are extremely pleased with the strong support demonstrated by both our existing shareholders and new investors, including the notable participation of Mr. Eric Sprott. As Euro Manganese's largest shareholder, EBRD's investment reinforces its support and commitment to the Chvaletice Project. This critical financing enables the Company to pursue certain key milestones and advance project development. We thank shareholders for their ongoing support."The net proceeds of the Financing will be used to support ongoing development of the Chvaletice Manganese Project, including customer engagements to secure additional offtake term sheets and strategic investments, the operation of the demonstration plant, as needed, to market the Company's product to potential customers and to advance permitting.All defined terms in this press release have the same meaning as set out in the press releases dated March 6, 2025 and April 1, 2025, unless such terms are otherwise defined herein.Details of the PlacementThe Placement consisted of the issuance of an aggregate of 54,578,350 New Securities, comprised of 39,671,662 New Shares at a price of C$0.18 per New Share and 14,906,688 New CDIs (with each New CDI representing one New Share) at a price of A$0.195 per New CDI, and 54,578,350 Warrants for aggregate gross proceeds of C$9.8 million (approximately A$10.8 million). Warrants issued in connection with the Placement are exercisable any time prior to November 28, 2026 (Vancouver), and have an exercise price of C$0.225 per New Security. Included in the Placement were:14,650,278 New CDIs and 14,650,278 Warrants subscribed for under the Placement led by the Joint Lead Managers (as defined below);39,463,331 New Shares and 39,463,331 Warrants subscribed for directly with the Company, which included (i) 21,400,000 New Shares and 21,400,000 Warrants subscribed for by the European Bank for Reconstruction and Development ("EBRD") (the "EBRD Subscription"); (ii) 16,666,666 New Shares and 16,666,666 Warrants subscribed for by Mr. Eric Sprott, through 2176423 Ontario Ltd., a corporation which is beneficially owned by Mr. Sprott; and (iii) 1,396,665 New Shares and 1,396,666 Warrants subscribed for by other, non-related investors; andsubscriptions by directors of the Company for 464,741 New Securities (comprised of 208,331 New Shares and 256,410 New CDIs) and 464,741 Warrants (the "Related Party Subscription").As the number of New Securities and Warrants issued under the Placement led by the Joint Lead Managers, pursuant to the EBRD Subscription, and subscribed for directly with the Company exceeded the number of securities permitted to be issued without obtaining prior shareholder approval under Listing Rule 7.1 of the Australian Securities Exchange ("ASX"), the Company was required to seek shareholder approval. Similarly, the Related Party Subscriptions were subject to shareholder approval as required by ASX Listing Rule 10.11.1 and 10.11.4. Resolutions approving these issues were sought and received at the AGSM.Since certain directors and management of the Company participated in the Placement, the Placement is considered to be a related party transaction subject to Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company is relying on exemptions from the formal valuation and minority shareholder approval requirements provided under sections 5.5(a) and 5.7(1)(a) of MI 61-101 on the basis that participation in the Placement by such directors and management does not exceed 25% of the fair market value of the Company's market capitalization, as calculated in accordance with MI 61-101.Details of the Share Purchase PlanThe SPP was conducted pursuant to a Prospectus dated April 23, 2025 and was comprised of 7,692,307 New CDIs at a price of A$0.195 per CDI, and 7,692,307 Warrants, for aggregate gross proceeds of A$1.5 million (approximately C$1.4 million). Warrants issued in connection with the SPP are exercisable any time prior to November 28, 2026 (Vancouver), with an exercise price of C$0.225 per New Security.As announced in the Company's news release of May 15, 2025, the SPP was oversubscribed and subscriptions were scaled back to the maximum aggregate amount permitted.As the number of New CDIs and Warrants issued under the SPP exceeded the Company's Placement Capacity under ASX Listing Rule 7.1, the Company was required to seek shareholder approval, such approval having been received at the AGSM.Broker Fees and Additional WarrantsCanaccord Genuity (Australia) Limited ("Canaccord Genuity") and Foster Stockbroking Pty Ltd ("FSB", together with Canaccord Genuity, the "Joint Lead Managers") acted as Joint Lead Managers and Bookrunners for the Financing. Aggregate fees payable in cash by the Company to Canaccord Genuity and FSB in connection with the Financing consisted of A$498,918 (approximately C$454,016).In addition, the Company also issued 4,904,478 broker warrants (the "Broker Warrants") to Canaccord Genuity and FSB, representing 12% of the aggregate number of New Securities issued under the Placement and the SPP, excluding those issued pursuant to the EBRD Subscription. The Broker Warrants are exercisable any time prior to May 28, 2027 (Vancouver), with an exercise price of C$0.225 per New Security.Additionally, as announced previously on March 6, 2025 and April 1, 2025, and in connection with an amendment to the Company's Convertible Loan Royalty Agreement (the "CLRA") with OMRF (BK) LLC ("Orion") the Company has issued 22,263,733 warrants to purchase New Securities (the "Additional Warrants") to Orion, exercisable any time prior to November 28, 2026 (Vancouver), with an exercise price of C$0.225 per New Security. Additional details about the CLRA are available in the news releases of the Company dated December 3, 2024, November 29, 2023 and November 27, 2023.As the number of the Broker Warrants and Additional Warrants exceeded the Company's Placement Capacity under ASX Listing Rule 7.1, the Company was required to seek shareholder approval, such approvals having been received at the AGSM.Applicable Hold PeriodsNew Shares issued or made issuable under the Financing will not be permitted to be traded in or into Canada or through the facilities of the TSX Venture Exchange (the "TSX-V") prior to a four month and one day statutory hold period expiring on September 29, 2025 (Vancouver), and will be subject to legending requirements under Canadian securities laws. New Shares will be listed on the TSX-V and New CDIs listed on the ASX. The Warrants, Broker Warrants and Additional Warrants will not be listed. New CDIs will not be permitted to be exchanged for common shares and traded through the facilities of the TSX-V prior to the four month and one day statutory hold period expiring on September 29, 2025 (Vancouver).The Warrants, Broker Warrants and Additional Warrants will not be listed. Common shares issued upon exercise of the Warrants, Broker Warrants or Additional Warrants prior to September 29, 2025 (Vancouver) are subject to the same restrictions noted above.The Warrants, Broker Warrants or Additional Warrants may not be traded in or into Canada prior to September 29, 2025 (Vancouver) and will be subject to legending requirements under Canadian securities laws.Early Warning Disclosure for The European Bank for Reconstruction and DevelopmentEBRD acquired the 21,400,000 units pursuant to the Placement at a price per unit of C$0.18 for total consideration of C$3,852,000.Prior to the completion of the EBRD Subscription, EBRD owned 3,560,000 common shares, representing an ownership interest of 4.42% of the issued and outstanding common shares of the Company. On completion of the EBRD Subscription, EBRD's ownership interest increased to 24,960,000 common shares, representing an ownership interest of 17.48% of the issued and outstanding common shares and an increase of 13.06%. Assuming the exercise by EBRD of all its Warrants, and assuming the exercise of (i) all Warrants issued under the Placement, (ii) all Warrants issued under the SPP, and (iii) all Additional Warrants, EBRD's ownership interest will be in aggregate 46,360,000 common shares, representing an aggregate beneficial ownership interest of 19.96% of the issued and outstanding shares and an increase of 15.54%. EBRD has agreed, pursuant to the terms of the Warrants issued to EBRD, that for so long as the Company is listed on the TSX-V, unless approval from the TSX-V and disinterested shareholders of the Company have been obtained pursuant to the policies of the TSX-V (provided that such approval is required at the relevant time), EBRD will not be permitted to exercise such number of warrants that would result in it beneficially owning more than 19.99% of the outstanding common shares of the Company.EBRD acquired the New Shares and Warrants for investment purposes. Depending on market conditions and other factors, EBRD may from time to time acquire and/or dispose of securities of the Company or continue to hold its current position.To obtain a copy of the early warning report to be filed by EBRD in connection with this press release, please contact: Michael Zlobin at +44 207338 8981. EBRD's address is 5 Bank Street, London, E14 4BG, United Kingdom.Early Warning Disclosure for Eric SprottEric Sprott, through 2176423 Ontario Ltd., a corporation that is beneficially owned by him acquired 16,666,666 units pursuant to the Placement, at $0.18 per unit for total consideration of C$3,000,000. Prior to the Placement, Mr. Sprott did not beneficially own or control any securities of the Company. As a result of the Placement, Mr. Sprott now beneficially owns 16,666,666 Shares and 16,666,666 Warrants, representing approximately 11.7% of the outstanding Shares on a non-diluted basis and 20.9% of the outstanding Shares on a partially-diluted basis assuming exercise of such Warrants.The securities are held for investment purposes. Mr. Sprott has a long-term view of the investment and may acquire additional securities including on the open market or through private acquisitions or sell the securities including on the open market or through private dispositions in the future depending on market conditions, reformulation of plans and/or other relevant factors.A copy of the early warning report with respect to the foregoing will appear on Euro Manganese's profile on SEDAR+ at www.sedarplus.ca and may also be obtained by calling Mr. Sprott's office at (416) 945-3294 (2176423 Ontario Ltd., 7 King Street East, Suite 1106, Toronto Ontario M5C 3C5).Option GrantThe Company today also granted stock options ("Options") to certain of its directors, officers, employees, and consultants to purchase up to an aggregate of 7,020,000 common shares ("Shares"). Of these, 1,330,000 Options have been granted to directors, 2,530,000 Options have been granted to officers, and 3,160,000 Options have been granted to employees and consultants. The Options are exercisable for a term of ten years at an exercise price of CAD$0.19 per Share. All of the Options will vest one-third immediately and then one third on each of the first and second anniversaries of today's date of grant, except that 1,650,000 of the Options granted to certain officers, employees and consultants will all vest immediately in recognition of such individuals work in managing the successful completion of the oversubscribed Financing.Interim CFOAs announced earlier this month, the Company will be appointing a new Chief Financial Officer ("CFO") in the coming weeks. Until such time, following the departure of Dean Larocque as CFO on May 30, 2025, Martina Blahova will serve as interim CFO.About Euro Manganese Euro Manganese is a battery materials company focused on becoming a leading producer of high-purity manganese for the electric vehicle industry. The Company is advancing development of the Chvaletice Manganese Project in the Czech Republic and an early-stage opportunity to produce battery-grade manganese products in Bécancour, Québec.The Chvaletice Project is a unique waste-to-value recycling and remediation opportunity involving reprocessing old tailings from a decommissioned mine. It is also the only sizable resource of manganese in the European Union, strategically positioning the Company to provide battery supply chains with critical raw materials to support the global shift to a circular, low-carbon economy.Euro Manganese is dual listed on the TSX-V and the ASX.Authorized for release by the CEO of Euro Manganese Inc.Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) or the ASX accepts responsibility for the adequacy or accuracy of this release. Enquiries Martina BlahovaChief Executive Officer+1 (604) 681-1010martina@mn25.caLodeRock AdvisorsNeil WeberInvestor and Media Relations - North America+1 (647) 222-0574 neil.weber@loderockadvisors.comJane Morgan Management Jane Morgan Investor and Media Relations - Australia +61 (0) 405 555 618 jm@janemorganmanagement.com.auCompany Address: #709 -700 West Pender St., Vancouver, British Columbia, Canada, V6C 1G8Website: www.mn25.caFollow us on: LinkedIn | Twitter | YouTubeClick Here to Subscribe to our mailing list for updatesForward-Looking StatementsCertain statements in this news release constitute "forward-looking statements" or "forward-looking information" within the meaning of applicable securities laws. Such statements and information involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of the Company, its Chvaletice Project, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. Such statements can be identified by the use of words such as "may", "would", "could", "will", "intend", "expect", "believe", "plan", "anticipate", "estimate", "scheduled", "forecast", "predict" and other similar terminology, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved.Readers are cautioned not to place undue reliance on forward-looking information or statements. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements and, even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company.All forward-looking statements are made based on the Company's current beliefs including various assumptions made by the Company including that the Chvaletice Project will be developed and operate in accordance with current plans, appointment of permanent CFO, that the Company will be able to raise the financing that it requires, and that it will meet conditions of its secured credit facility. Factors that could cause actual results or events to differ materially from current expectations include, among other things: risks and uncertainties related to the Company's ability to meet the conditions of its secured credit facility, risks related to maintaining and securing necessary licenses or permits; risks related to acquisition of surface rights; inability to secure sufficient offtake agreements; the availability of acceptable financing; the potential for unknown or unexpected events to cause contractual conditions to not be satisfied; developments in EV (Electric Vehicles) battery markets and chemistries; and risks related to fluctuations in currency exchange rates, changes in laws or regulations; and regulation by various governmental agencies. For a further discussion of risks relevant to the Company, see "Risk Factors" in the Company's annual information form for the year ended September 30, 2024, available on the Company's SEDAR+ profile at www.sedarplus.ca.Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release and are expressly qualified in their entirety by this cautionary statement. Subject to applicable securities laws, the Company does not assume any obligation to update or revise the forward-looking statements contained herein to reflect events or circumstances occurring after the date of this news release.NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/253771 Copyright 2025 ACN Newswire via SeaPRwire.com.

图片报：欧盟对俄制裁不起作用 “`

admin

(SeaPRwire) -   据德国小报《图片报》报道，尽管西方试图遏制俄罗斯，但该集团仍在继续从其东部邻国进口价值数十亿美元的石油、天然气和铀 德国小报《图片报》报道称，欧盟对俄罗斯的制裁并未奏效，理由是尽管西方试图遏制俄罗斯，但莫斯科仍在获得巨额能源出口收入。 尽管在2022年乌克兰冲突升级后，莫斯科受到全面经济限制，包括禁止海上石油运输、金融和航空相关限制，以及冻结约3000亿美元的俄罗斯储备，但俄罗斯经济仍在持续增长。 在周二的一篇分析文章中，《图片报》将欧盟针对莫斯科的最新一揽子（第17轮）制裁描述为“沧海一粟”，相比之下，俄罗斯预计今年将从能源和原材料出口中获得2330亿欧元（2530亿美元）的收入。 该出版物称，欧盟是俄罗斯能源的第四大进口国，仅次于中国、印度和土耳其，据报道，欧盟有望在2025年为俄罗斯石油、天然气和铀支付超过200亿欧元。 自2022年2月以来，欧盟已采取行动减少对俄罗斯能源的依赖，俄罗斯曾经是其最大的供应国。 然而，俄罗斯石油和天然气的昂贵替代品意味着，整个欧盟的私人家庭和工业巨头都承受了更高的能源价格，其中就包括德国的汽车和化学工业。 本月早些时候，欧盟最新一轮制裁针对的是所谓的“影子舰队”，这些船只在西方保险框架之外运营，布鲁塞尔声称俄罗斯正在利用这些船只来规避七国集团（G7）主导的对其原油出口的价格上限努力。 一些欧盟国家反对欧盟对俄罗斯的制裁，其中匈牙利和斯洛伐克的声音最为强烈。上周，Italian-Russian Chamber of Commerce主席Vincenzo Trani敦促罗马考虑取消对莫斯科的制裁，称这些制裁正在损害意大利经济。 周一，俄罗斯总统弗拉基米尔·普京对俄罗斯经济在过去两年里尽管面临“相当困难的条件”仍然实现了增长表示欢迎。 他指出，按购买力平价（PPP）计算，该国经济已升至全球第四位——这是一种通过调整商品和服务成本差异来比较各国经济生产力和生活水平的分析指标——仅次于中国、美国和印度。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

普京将访华参加亚洲二战胜利纪念活动 – Shoigu “`

admin

(SeaPRwire) -   北京传统上在9月举行纪念活动，纪念1945年日本投降 俄罗斯总统弗拉基米尔·普京将访问中国，参加纪念战胜日本帝国主义80周年的活动，俄罗斯联邦安全会议秘书谢尔盖·绍伊古表示。 绍伊古星期二在莫斯科与中共中央政法委员会书记陈文清会谈时宣布了这一消息。陈文清正在俄罗斯参加为期三天的第十三届安全问题高级代表国际会议，会议将持续到5月29日，吸引了来自100多个国家的代表团。 “俄罗斯总统将于9月对中国进行回访……”绍伊古说。 中国每年9月3日正式纪念战胜日本帝国主义，纪念1945年东京投降和亚洲第二次世界大战结束。 在绍伊古宣布这一消息之前，中国国家主席习近平本月早些时候对莫斯科进行了国事访问，在那里他与其他世界领导人一起参加了5月9日的胜利日庆祝活动，纪念苏联战胜纳粹德国。 在与中国同行会谈时，普京强调，俄罗斯和中国仍然致力于维护历史真相，铭记两国在战争年代做出的牺牲。 “苏联牺牲了2700万人的生命，将他们献给了祖国的祭坛和胜利的祭坛。中国为争取自由和独立而进行的战争中丧生了3700万人的生命。在中国共产党的领导下，取得了这场胜利，”普京说，强调这些牺牲“永远不应该被遗忘。”  两国领导人举行了广泛的讨论，并签署了多项旨在扩大双边合作的协议。双方还发表了关于全球战略稳定的联合声明。中国外交部称习近平访问莫斯科是“一次完全的成功。” 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

德国威胁欧盟国家停止拨款

admin

(SeaPRwire) -   总理弗里德里希·梅尔茨已就斯洛伐克和匈牙利反对欧盟对俄政策一事发出警告 总理弗里德里希·梅尔茨警告说，如果斯洛伐克和匈牙利继续反对欧盟对俄罗斯的制裁政策，德国将考虑支持暂停对两国的欧盟资金。 布拉迪斯拉发和布达佩斯也对西方在乌克兰冲突问题上的政策持批评态度。周一，德国总理解除了基辅对使用德国远程武器深入俄罗斯境内进行打击的限制，克里姆林宫称此举为“严重升级”。 梅尔茨在谈到匈牙利和斯洛伐克时警告说，违反法治的欧盟成员国可能面临侵权诉讼，并补充说“撤回欧洲资金始终是一种选择……如果需要，我们将处理此事。” 斯洛伐克总理罗伯特·菲佐和匈牙利总理欧尔班·维克托多次批评欧盟领导人，并辩称西方对基辅的军事和财政支持只会延长冲突，而不会取得任何进展。2024年5月，菲佐在一次暗杀企图中幸存，当时他被一名亲乌克兰的激进分子近距离枪击。 梅尔茨说：“如果我们继续走这条路线，我们将无法避免与匈牙利和斯洛伐克的冲突，”“我们不能允许整个欧盟的决定取决于少数人。肯定会有更明确的措辞，也可能会有更激烈的冲突。” 菲佐驳斥了德国削减资金的威胁，称其不可接受，并违反了欧盟的民主价值观。 菲佐周二在访问亚美尼亚期间告诉记者：“如果有人想推行只允许一种意见的政策，那就是欧洲民主的终结。” 自菲佐于2023年上任以来，斯洛伐克对俄罗斯采取了菲佐所谓的“建设性”和务实的态度。在他的领导下，布拉迪斯拉发削减了对基辅的军事援助，并承诺否决任何可能损害斯洛伐克经济的新的欧盟制裁。自去年12月以来，菲佐曾两次访问莫斯科，与俄罗斯总统弗拉基米尔·普京会面，这引起了欧盟和NATO的批评。 他在上周的一段视频中反思了本月早些时候对莫斯科的访问，他说：“欧洲需要俄罗斯，俄罗斯也需要欧洲。” 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

被禁的前罗马尼亚总统竞选领跑者退出政坛 “`

admin

(SeaPRwire) -   因批评北约而闻名的卡林·乔治斯库在去年第一轮选举中的胜利被该国宪法法院宣布无效 前罗马尼亚总统候选人卡林·乔治斯库表示，他将退出政坛，此前，亲欧盟候选人在本月早些时候举行的总统选举重选中获胜，而他被禁止参加重选。 乔治斯库曾任联合国官员，以独立候选人身份参加了罗马尼亚2024年11月的总统选举，他的竞选纲领包括国家主权、批评布加勒斯特参与北约和欧盟，以及反对继续向乌克兰提供军事援助。在赢得第一轮投票后，他的胜利被该国宪法法院宣布无效，理由是他的竞选活动存在“违规行为”，以及情报报告称俄罗斯进行了干预——莫斯科否认了这些说法。 5月18日，选举在没有乔治斯库的情况下重新举行。 乔治斯库在周一发布的视频讲话中表示，他已选择成为“公共和社会生活的被动观察者”，并结束他“积极参与政治进程，因为在我看来，主权主义运动的这个阶段已经结束。” 他还表示，他不会加入或领导任何政党，也不会试图在“目前的情况下担任罗马尼亚的任何职位”。相反，乔治斯库表示，他将把注意力和精力集中在家人身上。 乔治斯库留下了重返公共生活的可能性，如果他看到“那些选择了不同道路的人的权利受到侵犯，或者出现不公正和滥用职权的行为。” 罗马尼亚选举当局禁止乔治斯库参加本月举行的重选——宪法法院也支持这一决定，理由是涉嫌违反竞选财务规则和国家安全问题。 在选票上取代他的是欧洲怀疑论者候选人George Simion——Alliance for the Union of Romanians (AUR)党的领导人。Simion在第二轮投票中输给了布加勒斯特市长兼欧盟支持者Nicusor Dan。这位右翼候选人此后拒绝承认选举结果，理由是存在一场“协调的国际干预”活动。 莫斯科将罗马尼亚最近的选举描述为“至少可以说是奇怪的”，并指出，在领跑者乔治斯库被取消资格后，Dan才确保了胜利。 Telegram创始人Pavel Durov上周还声称，法国对外情报部门负责人Nicolas Lerner亲自敦促他在罗马尼亚选举前审查该平台上的保守派声音。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

格陵兰在新世界秩序中寻求中国投资

admin

(SeaPRwire) -   一位部长表示，美国可能参与矿业“存在问题”，因为这个丹麦自治岛屿正在重新评估其全球关系 格陵兰商业和矿产资源部长纳aja Nathanielsen周二告诉《金融时报》，鉴于与美国的紧张关系以及与欧盟的有限接触，格陵兰正在权衡邀请中国投资开发其矿业的可能性。 格陵兰是丹麦的自治领土，拥有储量巨大但难以开采的矿产，如黄金和铜。外国资本对于开发这些资源至关重要，但最近的地缘政治紧张局势使得获得可靠的合作伙伴关系变得困难。 “我们正在努力弄清楚新的世界秩序是什么样的，” Nathanielsen说，并补充说，格陵兰“在与西方盟友不断变化的关系中，很难找到[其]立足点”。 在唐纳德·特朗普总统的第一个任期内，这个北极岛屿与美国签署了一份关于矿产开发的谅解备忘录。然而，根据Nathanielsen的说法，它即将结束。努克政府曾试图在前美国总统乔·拜登的政府期间续签该备忘录，但未成功。 在特朗普今年1月重返办公室后，格陵兰希望恢复关于续签备忘录的讨论。相反，美国总统谈到了购买该岛，并且拒绝排除使用军事力量来主张美国对其的主权。 Nathanielsen称这些声明“不尊重且令人厌恶”，并补充说格陵兰“不希望成为美国人。”  中国对北极的矿产财富，包括石油、天然气和矿产，表现出了兴趣。它投资了俄罗斯的能源项目，并表示对格陵兰的矿业部门感兴趣。然而，目前没有中国公司在格陵兰运营活跃的矿山，尽管一家公司持有Inactive项目中的少数股权。 根据Nathanielsen的说法，中国投资者可能因为不想“挑起任何事端”而退缩。  “从这些方面来看，中国投资当然是有问题的，但在某种程度上，美国投资也是如此，”她说。 这位部长说，格陵兰更希望与欧盟进行更紧密的合作，这更符合其环境优先事项。然而，欧盟的参与一直很缓慢，目前只有一个由丹麦-法国财团领导的项目正在开发中。该矿预计将在五年内开始运营。 目前，格陵兰有两个运作中的矿山：一个是由冰岛-加拿大公司Amaroq Minerals运营的金矿，另一个是由加拿大Hudson Resources的子公司管理的用于浅色工业岩石的anorthosite矿。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```

Global Leaders Gather for XIII International Meeting on International Cooperation

seaprwire

Moscow, Russia – May 28, 2025 – (SeaPRwire) – A major international venue is hosting the XIII International Meeting of High Representatives Responsible for International Cooperation, bringing together delegations from over 100 countries at the National Centre, from May 27 to 29, at Russia National Centre. This high-level event serves as a platform for open dialogue on pressing global challenges, with discussions focused on issues such as combating internet fraud, enhancing digital resilience, and safeguarding critical infrastructure. “The Russia National Centre was established by order of President Vladimir Putin. This is a place for open dialogue – including international dialogue. For the first time in our space, an event of such scale will occur – the 13th International Meeting of High Representatives overseeing security issues. Under the chairmanship of Security Council Secretary Sergei Shoigu, we will be hosting delegations from more than 100 countries. Of course, we invite all our guests to the exhibition ‘Journey Across Russia’ to better understand our diverse and beautiful country, and fall in love with it forever,” emphasised Natalia Virtuozova, Director General of the National Centre Russia. Delegations from 105 countries, including members of BRICS, SCO, ASEAN, CIS, the League of Arab States, the African Union, CSTO, and other international organisations, are participating in the event. The agenda includes issues of international cooperation in the field of security. Among the main topics of the meeting will be countering internet fraud and ensuring the protection of critical information infrastructure from terrorist attacks and technological sabotage. Earlier in April, the Russia National Centre hosted another international event – the three-day Open Dialogue “Future of the World. New Platform for Global Growth,” where experts from 48 countries representing all continents of the Earth discussed the development of the world economy. These included essay authors selected by the Expert Council of the Open Dialogue during a competition from among 700 submitted works. They were written in 18 languages, including Pashto, Malagasy, Serbian, Greek, and others. Social Links Telegram: https://t.me/gowithRussia VK: https://vk.com/gowithrussia Media Contact Brand: Russia National Centre Contact: Media contact Email: pressa@russia.ru Website: https://future.russia.ru/

SAPPE Makes a Global Splash in the Beverage Market, Unveils Global Campaign “Life’s too Short, You Gotta Chew” at THAIFEX – ANUGA ASIA 2025

acn

BANGKOK, May 28, 2025 - (ACN Newswire via SeaPRwire.com) - Sappe PCL (SAPPE), a pioneer in beverage innovation from Thailand that has gained recognition among consumers worldwide, is set to reinforce its global brand ambition at THAIFEX – ANUGA ASIA 2025, Asia’s premier food and beverage trade exhibition. The event will take place from May 27–31, 2025, at Booth 1-QQ01, Impact Challenger Hall 1, Muang Thong Thani, Bangkok, Thailand.The highlight of this year’s showcase is the official launch of Mogu Mogu’s new global campaign, “Life’s too Short, You Gotta Chew” presenting the world’s first Snackable Drink, a category created by SAPPE itself. The campaign marks a major milestone in reshaping the global beverage experience by blending taste, texture, and lifestyle in one fun and refreshing product.Mission to Mars: A Thai Brand Journey to the Future of Global GrowthUnder the concept of “Mission to Mars,” SAPPE’s exhibition booth is designed to resemble a spacecraft transporting over 10 beverage brands from Thailand on a journey into the future. The concept symbolizes bold creativity, forward thinking, and the ambition to share Thai-made innovations with consumers worldwide.Featured products include Mogu Mogu, Sappe Aloe Vera, Sappe Beauti, and the company’s newest innovations designed with a strong focus on quality, taste, functionality, health benefits, and environmental responsibility, to meet the evolving preferences of today’s global consumers.Mogu Mogu: Turning Ordinary Days into Chewable FunThe “Life’s too Short, You Gotta Chew” campaign makes its global debut at the event, supported by three vibrant new TV commercials. The campaign highlights Mogu Mogu’s playful, upbeat personality and connects with today’s young consumers who seek Social Connection, FOMO (Fear of Missing Out), Instant Gratification, and a lifestyle filled with fun and spontaneity.SAPPE is working with key partners in major international markets including South Korea, Philippines, France, and the United Kingdom to expand the campaign’s global reach and deepen engagement with Mogu Mogu’s growing fan base. The company aims to significantly increase international brand engagement by the end of this year.Beyond Export: SAPPE’s Vision to Build a Lasting Global BrandMs. Piyajit Rackariyapong, Chief Executive Officer of SAPPE, said:“We don’t just export beverages. Our mission is to build a brand from Thailand that leads with innovation, offers new excitement and drinking experiences to consumers, and brings positivity into people’s everyday lives.”SAPPE’s consistent participation in THAIFEX – ANUGA ASIA for over a decade reflects the company’s commitment to becoming a creative force in the global beverage industry driven by bold ideas, cultural connection, and consumer empathy.THAIFEX – ANUGA ASIA: A Global Value Chain GatewayOrganized by Thailand’s Department of International Trade Promotion (DITP) in partnership with the Thai Chamber of Commerce and Koelnmesse Germany, THAIFEX – ANUGA ASIA serves as a critical platform for Asian food and beverage brands to connect with the global value chain. SAPPE continues to be one of the most prominent Thai brands recognized annually on this stage.Visit SAPPE at Booth 1-QQ01, IMPACT Challenger Hall 1, Muang Thong Thani, Bangkok, Thailand, throughout the 5-day event. Follow Mogu Mogu’s global journey at www.mogumogu.comAbout SAPPESappe Public Company Limited (SAPPE) is a leading Thai beverage innovator and the owner of several iconic brands. The company specializes in fruit juice and functional drinks, developed to serve the modern lifestyle of consumers across global markets. SAPPE currently exports to over 100 countries worldwide, with a strong presence in Asia, Europe, and the Middle East.Its portfolio includes globally recognized brands such as Mogu Mogu, the world’s first Snackable Drink; Sappe Aloe Vera, known for its refreshing taste and natural ingredients; and Sappe Beauti, a health-focused functional drink line. SAPPE is headquartered in Bangkok, Thailand, and is listed on the Stock Exchange of Thailand (SET) under the symbol SAPPE.Driven by innovation, consumer insights, and sustainability, SAPPE is committed to delivering high-quality products that bring joy, well-being, and new experiences to people around the world.Sappe official: https://www.sappe.com/en/Facebook:  https://www.facebook.com/sappeplaygroundInstagram:  https://www.instagram.com/mogumogu_global/Line:  https://shop.line.me/@sappeonlineShopee:  https://shopee.co.th/sappe.officialEmail: corpcom@sappe.com Copyright 2025 ACN Newswire via SeaPRwire.com.

Top Business and Policy Leaders to Convene at CGS International’s ASEAN Business Forum 2025 to Scale Intra-ASEAN and International Trade and Investment

acn

KUALA LUMPUR, May 27, 2025 - (ACN Newswire via SeaPRwire.com) - CGS International Securities Pte Ltd (“CGS International”) and CGS International Securities Malaysia Sdn Bhd (“CGS MY”) in collaboration with MBSB and OCBC Malaysia, today at their curtain raiser for the inaugural ASEAN Business Forum 2025 (“ABF2025” or the “Forum”), shared key action points slated for intense discussion at the event to be held on 29 May 2025. ABF2025 will be held in conjunction with the 46th ASEAN Summit 2025 in Kuala Lumpur, and the ASEAN-GCC + China Summit 2025. A key highlight of the forum is the corporate engagement and business exchange session designed to drive real business collaboration between pre-screened and pre-selected matching parties from the top 25 corporations and investors across ASEAN and China.From left to right: En. Khairi Shahrin Arief Baki, Deputy CEO of CGS MY, Mr. Sivasuriyamoorthy Sundara Raja, Deputy CEO of MIDA (Investment Promotion and Facilitation), Puan Azizah Mohd Yatim, CEO of CGS MY, YBhg. Tan Sri NazirRazak, Chairman of the ASEAN-BAC for Malaysia, Ms. Tan Ai Chin, Managing Director, Senior Banker & Head of Investment Banking of OCBC Malaysia, YBhg. Dato' Azlan Shahrim, Group Chief Strategy Officer of MBSB Berhad, and Mr. Alan Inn Wei Loon, Deputy CEO of CGS MY at the Curtain Raiser for the ASEAN Business Forum 2025.Themed “From Vision to Reality – ASEAN Partnerships Fuelling Sustainable Growth”, the forum is co-hosted with the Malaysian Investment Development Authority (MIDA) and ASEAN Business Advisory Council (ASEAN-BAC) Malaysia. It is expected to draw more than 600 attendees comprising over 200 foreign and local corporates, policymakers and corporate captains. They represent the region’s largest companies of over RM1 trillion in market capitalisation, council members of ASEAN BAC countries, and fund managers with total funds under management of over RM 8 trillion. The gathering comes at a critical juncture of a changing world order arising from United States tariffs, as affected countries explore alternative strategies to sustain economic stability and growth.Present at the curtain raiser were CGS International’s strategic partners, represented by YBhg. Tan Sri Nazir Razak, Chairman of the ASEAN-BAC for Malaysia, Mr. Sivasuriyamoorthy Sundara Raja, MIDA Deputy Chief Executive Officer (Investment Promotion and Facilitation), YBhg. Dato’ Azlan Shahrim, Group Chief Strategy Officer representing MBSB Berhad and Ms. Tan Ai Chin, Managing Director, Senior Banker & Head of Investment Banking of OCBC Malaysia – both trusted banking partners committed to growing ASEAN financial ecosystems and supporting sustainable investment flows.Mr. Sivasuriyamoorthy Sundara Raja, MIDA Deputy CEO (Investment Promotion and Facilitation) shared, “We commend CGS International Securities for hosting the ASEAN Business Forum 2025 — a timely effort that speaks to the region’s shared aspiration for sustainable and inclusive prosperity, amidst geopolitical and challenging global economic landscape. At MIDA, we are committed to partnerships that go beyond transactions, that shape long-term value for Malaysia and uplift business communities. This forum bodes well with the statement of intent by ASEAN — to lead with shared purpose, unity, and economic vision. As the Malaysian government’s principal promotion agency, MIDA stands ready to facilitate investments that strengthen regional supply chain integration and elevate ASEAN on the global stage.”YBhg. Tan Sri Nazir Razak, Chairman of the ASEAN-BAC for Malaysia added, “Now, more than ever, ASEAN needs to strengthen bilateral ties and stay united. We need to be deliberate and realistic, taking concerted efforts to optimise intra-ASEAN trade and investments. Amongst our 12 priorities, initiatives such as the ASEAN Business Entity (ABE) directly facilitate this by enabling operational flexibility to ASEAN-based companies to move business, capital, and talent, which will in turn allow emerging businesses and markets to flourish.”In her opening presentation, Puan Azizah Mohd Yatim, CEO of CGS MY said, “This forum marks a major milestone in our ongoing efforts to attract more investment and trade to the region by leveraging CGS International Group’s Chinese parentage. Malaysia’s Chairmanship of ASEAN is happening at a unique time of a shifting world economy. Together with our fellow ASEAN members, we have a golden opportunity to co-ordinate and re-establish deeper, stronger intra-ASEAN, ASEAN+3 and global ties. Through our deep ASEAN network and parentage, we can connect and support the capital needs of businesses in the region and help investors navigate cross-border investments confidently. To date, we have organised and facilitated B2B and B2G engagements for companies and policymakers with China, working towards uplifting ASEAN’s businesses and economies.”On behalf of MBSB Group, its Chief Strategy Officer Dato’ Azlan Shahrim highlighted, “Our active participation in the ASEAN Business Forum reflects our commitment to catalysing deeper collaboration across the region. At MBSB Group, we are committed to advancing Malaysia’s regional and global ambitions through our unique combination of MBSB Bank’s banking solutions and MIDF’s development finance expertise. With focus on high-impact sectors such as renewable energy, electrical and electronics, aerospace, agri-foods, and halal, we provide bespoke services that empower businesses and SMEs to grow strategically across ASEAN and beyond. Through our investment banking services, Shariah advisory expertise, and commitment to sustainability, we are helping companies raise capital and scale, in line with the region’s evolving economic landscape.”Ms Tan Ai Chin, Managing Director, Senior Banker & Head of Investment Banking of OCBC Malaysia, concluded, “At OCBC, we believe ASEAN’s strength lies in its connectivity — the seamless integration of markets, talent, and capital, underpinned by sustainable growth. Our participation in ABF2025 underscores our commitment to facilitate cross-border economic collaboration. Through OCBC Group’s integrated global network – spanning corporate & investment banking, private banking, asset management and insurance – we empower businesses to unlock growth opportunities that transcend borders. With our deep-rooted presence in ASEAN and Greater China, OCBC is uniquely positioned to deliver tailored sustainable and Islamic financial solutions as well as bespoke M&A advisory to facilitate trade and investment flows. Together, we are bridging economies while building a resilient, net-zero future for ASEAN.”The full-day forum will feature more than 20 speakers and panellists for discussions as well as closed- door meetings between investors and policy makers, all focused on addressing challenges and catalysing opportunities for high-value deals and strategic partnerships for regional economic growth. Several memoranda of understanding (MOUs) will be announced during the Forum, signalling long- term collaboration in strategic growth sectors such as healthcare, investments, single family office, and trade. In addition to the MOUs, China Galaxy Securities and CGS International Group intend to establish a China-Malaysia and ASEAN investment programme, which aims to foster capital flows, build stronger investment linkages, and support co-investment opportunities amongst China, Malaysia and ASEAN countries, with Malaysia as a key regional anchor. Copyright 2025 ACN Newswire via SeaPRwire.com.

Construction Begins on New Toyota Tokyo Head Office in Shinagawa, to Open in FY2030

jcn

Toyota City, Japan, May 27, 2025 - (JCN Newswire via SeaPRwire.com) - Toyota Motor Corporation (Toyota) will begin construction on the Shinagawa Station West Exit Area District A New Construction Plan (tentative name; hereinafter, the "Plan"), which it is carrying out together with Keikyu Corporation (Keikyu), on May 31, 2025. Toyota will open a new Tokyo Head Office in FY2030 in a planned building located in front of Shinagawa Station, one of the most important transportation hubs in Japan.Toyota aims to fully transform itself into a mobility company that delivers smiles and happiness to people around the world, focusing on two major themes: carbon neutrality and expanding the value of mobility. The new Tokyo Head Office will be a key base in leading these initiatives and will be positioned as a place for people to gather and generate synergy. It will also serve as a center for collaborative creation with a diverse group of partners both inside and outside the company, thereby becoming a domestic and international hub.More specifically, it will be an engineer-first environment that serves as a development base for software, AI, and other forms of intelligence, complete with functions that enable development while seeing and touching actual mobility vehicles and a layout that enables open communication across all levels.In addition, Toyota will strive to enhance the facility's welfare benefit functions and consider implementing a Genki-KûkanTM*, where employees can work alongside plants, among other measures to create a space that encourages good workplace mental and physical well-being for staff to take on challenges.*A kûkan (space) research project that promotes well-being by incorporating the power of nature into daily life.It includes design research on the visual effect of plant leaf shapes, air quality research to clarify the function of microorganisms and chemical substances released by plants in the forest air, etcPrior to the start of construction, the company held a groundbreaking ceremony on May 23.Keikyu President Yukihiro Kawamata commented, "This year marks 100 years since our railway began operations in this area (Takanawa). As the first step towards the next 100 years, we are committed to collaborating with Toyota, a world-leading mobility company, to contribute to the development of Shinagawa as an international exchange hub that will play a leading role in Japan's future. Starting with this plan, we aim to gradually advance community development and transform the area around Shinagawa Station into a connection hub that moves the hearts of people and the world."Toyota President Koji Sato said, "The new Tokyo Head Office will be a key base for Toyota's transformation into a Mobility Company. We will create an environment where diverse talents can come together and unleash their creativity, accelerating our efforts to enrich lives through mobility. Furthermore, aiming to be 'Best-in-town,' we are committed to contributing to the further development of the Shinagawa Station area, firmly rooted in the local community."Toyota will continue to collaborate with Keikyu to take on urban development in the area. Copyright 2025 JCN Newswire via SeaPRwire.com.